Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer

NCT03571633 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer
Operable Breast Cancer

Interventions

DRUG: Trastuzumab + Paclitaxel
DRUG: Pegfilgrastim

Sponsor

Centre Leon Berard

Collaborators

[object Object]